Lilly funds second factory line for inhaled insulin
Eli Lilly and Co. has agreed to fund a second manufacturing line at an Alkeres Inc. plant to make its Inhaled Insulin System powder. Lilly’s system, to be marketed as an alternative for types 1 and 2 diabetes, is in phase 3 clinical trials. The deal also makes Cambridge, Mass.-based Alkeres the exclusive manufacturer of […]